AvePoint Media Contact
Tel: +1 201-201-8143
Apex Technology Acquisition Corp. and AvePoint, Inc. Announce Registration Statement Effectiveness and June 30, 2021 Scheduled Special Meeting to Approve Business Combination
BURLINGAME, Calif. & JERSEY CITY, N.J., June 2, 2021 -- Apex Technology Acquisition Corp. (NASDAQ: APXT, “Apex”), a publicly-traded special purpose acquisition company, and AvePoint, Inc. (“AvePoint”), the largest data management solutions provider for Microsoft 365, today announced that Apex’s registration statement on Form S-4 (File No. 333-252712), relating to the previously announced merger of Apex and AvePoint, has been declared effective by the U.S. Securities and Exchange Commission. Apex also announced that it will hold the extraordinary general meeting of stockholders (the “Special Meeting”) on Wednesday, June 30, 2021 at 10:00 AM ET to, among other things, allow its stockholders to vote to approve the proposed Business Combination with AvePoint. The Special Meeting will be completely virtual and conducted via live webcast at the following address: www.virtualshareholdermeeting.com/APXT2021SM.
Stockholders of record of Apex common stock as of the close of business on the record date of June 1, 2021 may vote at or before the Special Meeting.
If the proposals at the Special Meeting are approved, the parties anticipate that the Business Combination will close shortly thereafter, subject to the satisfaction or waiver (as applicable) of all other closing conditions. Upon the closing of the Business Combination, the parties expect that the combined company will operate as AvePoint, Inc., and that the shares of common stock and the warrants of the combined company will be listed on The Nasdaq Stock Market LLC under the symbols “AVPT” and “AVPTW,” respectively.
Apex stockholders who need assistance voting, have questions regarding the Special Meeting, or would like to request documents may contact Apex Technology Acquisition Corp, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, by telephone at (619) 736-6855or by email at email@example.com, or Apex’s proxy solicitor, MacKenzie Partners, Inc., 1407 Broadway, 27th Floor, New York, New York 10018, by telephone at (800) 322-2885 (for individuals) or (212) 929-5500 (for banks and brokerages) or by email at firstname.lastname@example.org.
About Apex Technology Acquisition Corp.
Apex is a special purpose acquisition corporation led by co-CEOs Jeff Epstein, the former CFO of Oracle, and Brad Koenig, the former head of Goldman Sachs’ global technology investment banking team. For more information about Apex, visit https://apexacquisitioncorp.com/
IMPORTANT LEGAL INFORMATION
This press release contains certain forward-looking statements within the meaning of the federal securities laws including statements regarding the expected outcome of the Special Meeting to approve the Business Combination between AvePoint and Apex, the anticipated consummation date of the Business Combination, the expected listing of the combined company’s stock on the Nasdaq Stock Market LLC, and the future performance and market opportunities of the combined company. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: changes in the competitive and regulated industries in which AvePoint operates, variations in operating performance across competitors, changes in laws and regulations affecting AvePoint's business and changes in AvePoint’s ability to implement business plans, forecasts, and to identify and realize additional opportunities, and the risk of downturns in the market and the technology industry. You should carefully consider the foregoing factors and the other risks and uncertainties described in the "Risk Factors" section of the registration statement on Form S-4 discussed below and other documents filed by Apex from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and AvePoint and Apex assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Neither AvePoint nor Apex gives any assurance that either AvePoint or Apex, or the combined company, will achieve its expectations.
No Offer or Solicitation
This press release shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the business combination discussed herein. This press release also shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act of 1933, as amended, or an exemption therefrom.
Important Information for Investors and Stockholders
This press release relates to a proposed transaction between AvePoint and Apex. In connection with the proposed transaction, Apex has filed a registration statement on Form S-4 with the SEC which also includes a document that serves as a prospectus and proxy statement of Apex, referred to as a proxy statement/prospectus. A proxy statement/prospectus will be sent to all Apex stockholders. Apex will file other documents regarding the proposed transaction with the SEC. Before making any voting decision, investors and security holders of Apex are urged to read the registration statement, the proxy statement/prospectus and all other relevant documents filed or that will be filed with the SEC in connection with the proposed transaction as they become available because they will contain important information about the proposed transaction.
Investors and security holders are able to obtain free copies of the registration statement, the proxy statement/prospectus, and all other relevant documents filed or that will be filed with the SEC by Apex through the website maintained by the SEC at www.sec.gov. The information contained on, or that may be accessed through, the websites referenced in this press release is not incorporated by reference into, and is not a part of, this press release.
Participants in the Solicitation
Apex and its directors and officers may be deemed participants in the solicitation of proxies of Apex’s stockholders in connection with the proposed transaction. Apex’s stockholders and other interested persons may obtain, without charge, more detailed information regarding the directors and officers of Apex in the registration statement containing the proxy statement/prospectus which has been filed with the SEC.
Collaborate with Confidence: AvePoint provides the most advanced platform to optimize SaaS operations and secure collaboration.
Over 17,000 customers worldwide rely on our solutions to modernize the digital workplace across Microsoft, Google, Salesforce and other collaboration environments.
AvePoint's global channel partner program includes over 3,500 managed service providers, value added resellers and systems integrators, with our solutions available in more than 100 cloud marketplaces. To learn more, visit https://www.avepoint.com/uk.
All product and company names herein may be trademarks of their registered owners.